-
Most Popular
Search Results
240 results for BID
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the second quarter of 2024.
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024
MBIO stock results show that Mustang Bio beat analyst estimates for earnings per share the second quarter of 2024.
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2024.
KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024
KRRO stock results show that Korro Bio missed analyst estimates for earnings per share the second quarter of 2024.
3 Nuclear Fusion Stocks Energizing the Future
Although pure-play nuclear fusion stocks still are a long ways away, investors can plan ahead with these relevant ideas.
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Beats Revenue for Q2 2024
PLX stock results show that Protalix BioTherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
AVGO Buy Alert: Broadcom Stock Is Poised to Benefit From the Ongoing AI Boom
With Big Tech spending a great deal on data center equipment, Broadcom stock is likely to benefit significantly form the trend.
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024.
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Why ARM Stock Remains a Top Contender in the AI Chip Race
Investors would be smart to buy-the-dip in this chipmaker, which has a bright future and whose stock is likely to rebound.
SBIG Stock Earnings: SpringBig Holdings Meets EPS, Misses Revenue for Q2 2024
SBIG stock results show that SpringBig Holdings met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024
BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CLOV Stock Alert: What to Know About Clover Health’s Big Insider Buy
CLOV stock sold for under $1 per share recently. Clover could be on the verge of a sale, or this could be a short squeeze.
What Are the Hottest Quantum Computing Stocks Right Now? 3 Top Picks.
Quantum computing is a big deal and governments are pouring billions into research. Here are the quantum computing stocks to keep an eye on.
Facing Reality: AMC Stock Is Headed for Brutality and Fatality
Like a bad movie, AMC stock is heading toward a disappointing ending as AMC Entertainment discloses falling revenue and an earnings loss.
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.
3 3D Printing Stocks With Promising Industrial Applications
The next few years could see big growth in 3D printing. Grab these 3D printing stocks that have some of the most promising applications.
PALI Stock Earnings: Palisade Bio Misses EPS for Q2 2024
PALI stock results show that Palisade Bio missed analyst estimates for earnings per share the second quarter of 2024.
5 Tech Stocks to Buy on the Rebound
Don’t want to miss out on this year’s breakout stocks? These five tech companies might be on the brink of something big.
Fisker Stock Alert: EV Maker Receives Approval for Fire Sale
Fisker stock dropped 70% today, even despite the promising news that the company will be allowed to sell EVs to American Lease.
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
ENTX Stock Earnings: Entera Bio Meets EPS for Q2 2024
ENTX stock results show that Entera Bio met analyst estimates for earnings per share the second quarter of 2024.
5 – 10 of 240 results
